There are an estimated 200 million cases of malaria worldwide each year, and around 600,000 deaths. But the last 15 years represent a success story in the fight against the disease: Increased investment in treatment and prevention have cut the death rate nearly in half. Now, researchers warn that resistance to the primary drug used to treat malaria is spreading. A new study has detected a resistant strain in Myanmar near the Indian border, raising concerns that resistance could soon extend its hold to sub-Saharan Africa, where more than 90 percent of malaria deaths occur. Diane and her guests discuss new concerns about combating malaria worldwide.
Rethinking leadership in the U.S. African AmericanStudies professor Eddie S. Glaude Jr. says Americans have looked to the political class to create a just democracy for too long – and it hasn't worked. In a new book he argues that we are the leaders we have been looking for and explains what that means for the 2024 election.
Menopause. Once a taboo topic, the "m" word is having a moment – among celebrities, in the media, and in Washington, where President Biden recently signed an order that supports research into women's health. Dr. Sharon Malone says it's about time, and explains why understanding "the change" is critical for a woman's ability to get – and stay -- healthy.
Donald Trump regularly ends his rallies with prayer. He has repeatedly compared himself to Jesus. And last week he started selling a version of the Bible. Robert P. Jones of the Public Religion Research Institute weighs in on Trump’s growing embrace of Christianity.
Donald Trump has made cognitive ability a central issue of the presidential race. But he rarely talks about his own family's experience with dementia. The Washington Post's Michael Kranish on Fred Trump Senior's Alzheimer's disease and what voters deserve to know about a candidate's mental fitness.